Trade war with China to hit US healthcare

The U.S. heavily relies on Chinese imports for medications, raising concerns about supply chain disruptions, increased costs from tariffs, and potential health inequality during crises like the COVID-19 pandemic. These dependencies could lead to shortages, especially if tariffs disrupt global supply chains or cause price increases for generic drugs and APIs used in multiple medications. Additionally, reliance on foreign sources may widen health disparities globally and strain domestic manufacturing sectors, potentially harming job markets while also complicating international trade dynamics and raising the cost of imports worldwide.